Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

pharmacia Corporation

Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. We have built a portfolio of outstanding products, led by our key growth drivers: CELEBREX® (celecoxib capsules), CAMPTOSAR® (irinotecan hydrochloride injection), XALATAN® (latanoprost ophthalmic solution), DETROL®LA (tolterodine tartrate extended release capsules), and ZYVOX™ (linezolid injection, tablets, and for oral suspension).



Pharmacia's innovative medicines and other products save lives and enhance health and wellness. Pharmacia's 59,000 people in more than 60 countries work together with many diverse stakeholders to bring these benefits to people around the world, and to create new health solutions for the future.


Contact Details:
700 chesterfield parkway north
st. louis
MO
63198
United States of America
Tel:636-737-7295
Fax:636-737-6480
Email:gerald.f.casperson@stl.monsanto.com
WWW:

www.pharmacia.com/




Loading...

Recent Publications by pharmacia Corporation:

Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates.
PNU-286607 is the first member of a promising, novel class of...
13th June, 2009
Infectious Diseases Medicinal Chemistry, Pharmacia Corporation, 301 J Am Chem Soc. 2009 Mar 25;131(11):3991-7.
DOI Direct Link
Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.
By using a detergent-washed membrane preparation, the interaction of the...
21st April, 2009
Pharmacia Corp., Kalamazoo, Michigan 49001, USA. Antimicrob Agents Chemother. 2009 Feb;53(2):496-504. Epub 2008 Dec 1.
DOI Direct Link
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
QPT-1 was discovered in a compound library by high-throughput screening...
31st January, 2009
Infectious Diseases Biology and Medicinal Chemistry, Pharmacia Antimicrob Agents Chemother. 2008 Aug;52(8):2806-12. Epub 2008 Jun 2.
DOI Direct Link
Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis.
OBJECTIVES: The aim of this study was to characterize the mechanism of...
7th November, 2008
Infectious Diseases Biology, Pharmacia Corporation, 301 Henrietta Street, J Antimicrob Chemother. 2008 Oct;62(4):720-9. Epub 2008 Jun 19.
DOI Direct Link
Nimodipine: test your drug IQ.
Find out how this calcium channel blocker treats cerebral vasospasm after...
18th September, 2008
Hospice Pharmacia, Division of excelleRx, Philadelphia, PA, USA. Nursing. 2008 Jul;38(7):56cc1-2.
DOI Direct Link

View more pharmacia Corporation research publications.

BioNews Results for pharmacia Corporation:

Schering-Plough Chairman and CEO Fred Hassan Joins Time Warner's Board of Directors
NewsBlaze:  Oct 30 2009 7:30AM Matching: pharmacia
ERYtech Pharma Reinforces its Supervisory Board and its Scientific Board
Pharma Live:  Oct 30 2009 11:39PM Matching: pharmacia
ERYtech Pharma Reinforces its Supervisory Board and its Scientific Board
Pharmacy Choice:  Oct 30 2009 10:57PM Matching: pharmacia
ERYtech Pharma Reinforces its Supervisory Board and its Scientific Board
Freshnews.com:  Oct 30 2009 6:50PM Matching: pharmacia
Pediatric Exclusivity Granted
FDA:  Oct 30 2009 6:38PM Matching: pharmacia
Promote your company here: BioNewsCast - Press Release Distribution

View more pharmacia Corporation news.

pharmacia Corporation Clinical Trials:

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

pharmacia Corporation Patents:

US Patent No.Title
7208490 Tricyclic tetrahydroquinoline antibacterial agents
7244755 Hydroxypropylamines
7247627 Salts and polymorphs of a pyrrole-substituted indolinone compound
7247706 Double mutant alpha-7 nicotinic acetylcholine receptors
7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors

View more pharmacia Corporation patents.

pharmacia Corporation (PHA) Financial information Links from Barchart

PHA Quote from from Barchart.com
PHA Chart from from Barchart.com
PHA Profile from from Barchart.com
PHA Opinion from from Barchart.com

View more pharmacia Corporation finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 510 individuals from pharmacia Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 914 times since April 2007, the link to the organisation's website has been followed 159 times

Recent Search Terms used to find this page: Pharmacia Corporation | pharmacia corporation | pharmacia corporation website | Pharmacia Corporation | pharmacia corporation | pharmacia corporation | PHARMACIA CORPORATION | pharmacia corporation | Tolterodine pharmacia discovered | Discovery Research, Pharmacia Corporation, 700 Chesterfield Parkway North, | .

Search for more companies in st. louis

Search for more companies in MO



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for pharmacia Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.